FDA Inspection 707726 — Egis Pharmaceuticals PLC
The FDA completed an inspection of Egis Pharmaceuticals PLC on Jan 28, 2011 in Budapest. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 28, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Budapest (Hungary)